Cargando…
Systematic profiling of ferroptosis gene signatures predicts prognostic factors in esophageal squamous cell carcinoma
We developed a predictive model associated with ferroptosis to provide a more comprehensive view of esophageal squamous cell carcinoma (ESCC) immunotherapy. Gene expression data and corresponding clinical outcomes were obtained from the GEO and The Cancer Genome Atlas (TCGA) databases, and a ferropt...
Autores principales: | Lu, Tong, Xu, Ran, Li, Qi, Zhao, Jia-ying, Peng, Bo, Zhang, Han, Guo, Ji-da, Zhang, Sheng-qiang, Li, Hua-wei, Wang, Jun, Zhang, Lin-you |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8080401/ https://www.ncbi.nlm.nih.gov/pubmed/33981829 http://dx.doi.org/10.1016/j.omto.2021.02.011 |
Ejemplares similares
-
Identification and analysis of a prognostic ferroptosis and iron-metabolism signature for esophageal squamous cell carcinoma
por: Zhao, Mengnan, et al.
Publicado: (2022) -
A Novel Ferroptosis-Related Biomarker Signature to Predict Overall Survival of Esophageal Squamous Cell Carcinoma
por: Song, Jiahang, et al.
Publicado: (2021) -
A risk prognostic model for patients with esophageal squamous cell carcinoma basing on cuproptosis and ferroptosis
por: Li, Jianan, et al.
Publicado: (2023) -
Ferroptosis-Related lncRNA Signature Correlates with the Prognosis, Tumor Microenvironment, and Therapeutic Sensitivity of Esophageal Squamous Cell Carcinoma
por: Zhu, Jiahao, et al.
Publicado: (2022) -
A Prognostic Signature Based on Immunogenomic Profiling Offers Guidance for Esophageal Squamous Cell Cancer Treatment
por: Gao, Jianyao, et al.
Publicado: (2021)